Logo image
Therapeutic N -heterocyclic carbenes: an interview with Alejandro Bugarin
Journal article   Peer reviewed

Therapeutic N -heterocyclic carbenes: an interview with Alejandro Bugarin

Alejandro Bugarin
Future medicinal chemistry, Vol.14(13), pp.941-942
07-2022
PMID: 35611681

Abstract

anticancer drug antimicrobial drug gold interview N-heterocyclic carbene palladium silver
Dr Bugarin is currently an Associate Professor of Chemistry and Physics at Florida Gulf Coast University. He has published more than 50 peer-reviewed publications (h-index = 18). His research group is developing new methodology to improve or reveal novel reactivity of triazenes, N-Heterocyclic carbenes, heterobimetallic catalysts, and other versatile molecules. In addition, he recently joined research efforts to build on the isolation, characterization, and biological evaluation of natural products.

Metrics

21 Record Views
3 Times Cited - Scopus

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

Logo image